|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Common Stock | $ 39.04 | 11/01/2005 | D | 1,281 | (3) | 05/27/2015 | Common Stock | 1,281 | $ 4.86 | 0 | D | ||||
Common Stock | $ 30.15 | 11/01/2005 | D | 1,658 | (4) | 05/25/2014 | Common Stock | 1,658 | $ 13.75 | 0 | D | ||||
Common Stock | $ 24.15 | 11/01/2005 | D | 2,070 | (5) | 05/24/2012 | Common Stock | 2,070 | $ 19.75 | 0 | D | ||||
Common Stock | $ 7.6 | 11/01/2005 | D | 2,193 | (6) | 05/25/2011 | Common Stock | 2,193 | $ 36.3 | 0 | D | ||||
Common Stock | $ 20.06 | 11/01/2005 | D | 2,493 | (7) | 05/22/2013 | Common Stock | 2,493 | $ 23.84 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
WALKER JOHN E 5524 W. 61ST TERRACE COUNTRYSIDE, KS 66202 |
X |
John E. Walker by Randy Shelton attorney-in-fact | 11/01/2005 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Disposition of shares in the merger between the issuer and a wholly-owned subsidiary of Quest Diagnostics Incorporated ("Merger"). |
(2) | Shares owned by the Trustee of the Deborah Walker revocable trust dated January 24, 1990 and her successors in trust. |
(3) | This option, which provided for vesting in three equal annual installments beginning May 27, 2006, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share. |
(4) | This option, which provided for vesting in three equal annual installments beginning May 25, 2005, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share. |
(5) | This option, which provided for vesting in three equal annual installments beginning May 24, 2003, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share. |
(6) | This option, which provided for vesting in three equal annual installments beginning May 25, 2002, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share. |
(7) | This option, which provided for vesting in three equal annual installments beginning May 22, 2004, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share. |